Clinical trial
Effect of Symbicort on GR Localisation in Asthma
NCT00159263 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00159263 |
|---|---|
| Title | Effect of Symbicort on GR Localisation in Asthma |
| Official title | Effect of Symbicort on GR (Glucocorticoid Receptor) Translocation in Induced Sputum in Comparison With Budesonide, Formoterol and Placebo. A Single Dose Exploratory Study in Patients With Mild Asthma |
| Lead sponsor | Imperial College London, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Placebos, Formoterol Inhalant Powder, Budesonide Powder, Budesonide and Formoterol Product |
| Enrollment | 10 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 27, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: